Bioinformation Therapy for Liver Cancer
NCT03239158
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Liver, Cancer of, Non-Resectable
Interventions
DEVICE:
Cancer ablation
DRUG:
Life information rehabilitation therapy
Sponsor
Fuda Cancer Hospital, Guangzhou
Collaborators
[object Object]